Actively Recruiting
IN-Stent RestenosIs Detection and Treatment by Optical Coherence Tomography Comparing OCT-Guided Versus Angiography-Only PCI for Coronary In-Stent Restenosis
Led by San Luigi Gonzaga Hospital · Updated on 2025-01-16
360
Participants Needed
12
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating the treatment of coronary in-stent restenosis (ISR), a condition where the artery narrows again after stent placement, despite advances in drug-eluting stents. This trial compares two methods of guiding percutaneous coronary intervention (PCI) for ISR: one using intracoronary optical coherence tomography (OCT) along with angiography, and the other using angiography alone. The goal is to understand whether OCT guidance improves acute PCI performance for ISR patients. Participants with ISR showing 70% to 99% narrowing in a vessel between 2.25 and 5.75 mm will be randomly assigned to two groups. The first group will have PCI guided by OCT and angiography, with OCT runs before and after PCI, and additional OCT imaging allowed during the procedure. The second group will have PCI guided only by angiography, but OCT imaging will still be performed before and after PCI without the operator seeing the OCT results to maintain blinding. Operators in both groups may use various approved tools and techniques during PCI as needed. During the study, patients will undergo imaging and PCI procedures with detailed documentation of the treatment plans and any changes after OCT review. Researchers will measure changes in artery cross-sectional area after PCI as the primary outcome. Safety and procedural details will be closely monitored. The total participation includes the PCI procedure and follow-up imaging to assess treatment effectiveness.
CONDITIONS
Official Title
Intracoronary Optical Coherence Tomography Guidance Vs. Angiography Only Guidance for Treatment of Coronary In-stent Restenosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Age 18 years or older
- Scheduled for angiography due to stable or acute coronary syndrome and suitable for PCI by femoral or radial access
- Coronary in-stent restenosis with 70% to 99% narrowing in at least two angiographic projections in a vessel sized 2.25 to 5.75 mm, confirmed after nitroglycerine administration
- Stable hemodynamic condition
You will not qualify if you...
- Unable to give informed consent
- Currently participating in another clinical study involving an investigational product
- OCT imaging not technically feasible at the target vessel site
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 12 locations
1
Osp Aosta
Aosta, Aosta, Italy
Actively Recruiting
2
Biella
Biella, Biella, Italy
Actively Recruiting
3
Osp. S. Croce e Carle
Cuneo, Cuneo, Italy
Actively Recruiting
4
Ospedale Universitario di Ferrara
Cona, Ferrara, Italy
Actively Recruiting
5
Osp Universitario S. Marino
Genova, Genova, Italy
Actively Recruiting
6
Infermi Hospital, Rivoli ASLTO3
Rivoli, Italy, Italy, 10100
Actively Recruiting
7
Ospedale di Trapani
Trapani, Trapani, Italy
Actively Recruiting
8
AOU San Luigi Gonzaga
Orbassano, Turin, Italy, 10100
Actively Recruiting
9
AO Mauriziano
Turin, Turin, Italy, 10100
Actively Recruiting
10
AOU Città della Salute e della Scienza
Turin, Turin, Italy, 10100
Actively Recruiting
11
Osp. Giovanni Bosco
Turin, TURIN, Italy, 10100
Actively Recruiting
12
Osp Vercelli
Vercelli, Vercelli, Italy
Actively Recruiting
Research Team
E
Enrico Cerrato, MD, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here